Global and China Passive Transdermal Drug Delivery Market Insights, Forecast to 2026

Global and China Passive Transdermal Drug Delivery Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Passive Transdermal Drug Delivery Product Introduction
1.2 Market Segments
1.3 Key Passive Transdermal Drug Delivery Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Passive Transdermal Drug Delivery Market Size Growth Rate by Type
1.4.2 Microfluidics
1.4.3 Smart Pill Technology (SPT)
1.5 Market by Application
1.5.1 Global Passive Transdermal Drug Delivery Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Passive Transdermal Drug Delivery Market Size, Estimates and Forecasts
2.1.1 Global Passive Transdermal Drug Delivery Revenue 2015-2026
2.1.2 Global Passive Transdermal Drug Delivery Sales 2015-2026
2.2 Global Passive Transdermal Drug Delivery, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Passive Transdermal Drug Delivery Historical Market Size by Region (2015-2020)
2.3.1 Global Passive Transdermal Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Passive Transdermal Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Passive Transdermal Drug Delivery Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Passive Transdermal Drug Delivery Sales Forecast by Region (2021-2026)
2.4.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Region (2021-2026)
3 Global Passive Transdermal Drug Delivery Competitor Landscape by Players
3.1 Global Top Passive Transdermal Drug Delivery Sales by Manufacturers
3.1.1 Global Passive Transdermal Drug Delivery Sales by Manufacturers (2015-2020)
3.1.2 Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2015-2020)
3.2 Global Passive Transdermal Drug Delivery Manufacturers by Revenue
3.2.1 Global Passive Transdermal Drug Delivery Revenue by Manufacturers (2015-2020)
3.2.2 Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Passive Transdermal Drug Delivery Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Passive Transdermal Drug Delivery Revenue in 2019
3.2.5 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Passive Transdermal Drug Delivery Price by Manufacturers
3.4 Global Passive Transdermal Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Passive Transdermal Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Passive Transdermal Drug Delivery Product Type
3.4.3 Date of International Manufacturers Enter into Passive Transdermal Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Passive Transdermal Drug Delivery Market Size by Type (2015-2020)
4.1.1 Global Passive Transdermal Drug Delivery Sales by Type (2015-2020)
4.1.2 Global Passive Transdermal Drug Delivery Revenue by Type (2015-2020)
4.1.3 Passive Transdermal Drug Delivery Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Passive Transdermal Drug Delivery Market Size Forecast by Type (2021-2026)
4.2.1 Global Passive Transdermal Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 Passive Transdermal Drug Delivery Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Passive Transdermal Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Passive Transdermal Drug Delivery Market Size by Application (2015-2020)
5.1.1 Global Passive Transdermal Drug Delivery Sales by Application (2015-2020)
5.1.2 Global Passive Transdermal Drug Delivery Revenue by Application (2015-2020)
5.1.3 Passive Transdermal Drug Delivery Price by Application (2015-2020)
5.2 Passive Transdermal Drug Delivery Market Size Forecast by Application (2021-2026)
5.2.1 Global Passive Transdermal Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global Passive Transdermal Drug Delivery Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Passive Transdermal Drug Delivery Market Size YoY Growth 2015-2026
6.1.1 China Passive Transdermal Drug Delivery Sales YoY Growth 2015-2026
6.1.2 China Passive Transdermal Drug Delivery Revenue YoY Growth 2015-2026
6.1.3 China Passive Transdermal Drug Delivery Market Share in Global Market 2015-2026
6.2 China Passive Transdermal Drug Delivery Market Size by Players (International and Local Players)
6.2.1 China Top Passive Transdermal Drug Delivery Players by Sales (2015-2020)
6.2.2 China Top Passive Transdermal Drug Delivery Players by Revenue (2015-2020)
6.3 China Passive Transdermal Drug Delivery Historic Market Review by Type (2015-2020)
6.3.1 China Passive Transdermal Drug Delivery Sales Market Share by Type (2015-2020)
6.3.2 China Passive Transdermal Drug Delivery Revenue Market Share by Type (2015-2020)
6.3.3 China Passive Transdermal Drug Delivery Price by Type (2015-2020)
6.4 China Passive Transdermal Drug Delivery Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Passive Transdermal Drug Delivery Sales Forecast by Type (2021-2026)
6.4.2 China Passive Transdermal Drug Delivery Revenue Forecast by Type (2021-2026)
6.4.3 China Passive Transdermal Drug Delivery Price Forecast by Type (2021-2026)
6.5 China Passive Transdermal Drug Delivery Historic Market Review by Application (2015-2020)
6.5.1 China Passive Transdermal Drug Delivery Sales Market Share by Application (2015-2020)
6.5.2 China Passive Transdermal Drug Delivery Revenue Market Share by Application (2015-2020)
6.5.3 China Passive Transdermal Drug Delivery Price by Application (2015-2020)
6.6 China Passive Transdermal Drug Delivery Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Passive Transdermal Drug Delivery Sales Forecast by Application (2021-2026)
6.6.2 China Passive Transdermal Drug Delivery Revenue Forecast by Application (2021-2026)
6.6.3 China Passive Transdermal Drug Delivery Price Forecast by Application (2021-2026)
7 North America
7.1 North America Passive Transdermal Drug Delivery Market Size YoY Growth 2015-2026
7.2 North America Passive Transdermal Drug Delivery Market Facts & Figures by Country
7.2.1 North America Passive Transdermal Drug Delivery Sales by Country (2015-2020)
7.2.2 North America Passive Transdermal Drug Delivery Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Passive Transdermal Drug Delivery Market Size YoY Growth 2015-2026
8.2 Europe Passive Transdermal Drug Delivery Market Facts & Figures by Country
8.2.1 Europe Passive Transdermal Drug Delivery Sales by Country
8.2.2 Europe Passive Transdermal Drug Delivery Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Passive Transdermal Drug Delivery Market Size YoY Growth 2015-2026
9.2 Asia Pacific Passive Transdermal Drug Delivery Market Facts & Figures by Country
9.2.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2015-2020)
9.2.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Passive Transdermal Drug Delivery Market Size YoY Growth 2015-2026
10.2 Latin America Passive Transdermal Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America Passive Transdermal Drug Delivery Sales by Country
10.2.2 Latin America Passive Transdermal Drug Delivery Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Passive Transdermal Drug Delivery Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Passive Transdermal Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Country
11.2.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 3M
12.1.1 3M Corporation Information
12.1.2 3M Description and Business Overview
12.1.3 3M Sales, Revenue and Gross Margin (2015-2020)
12.1.4 3M Passive Transdermal Drug Delivery Products Offered
12.1.5 3M Recent Development
12.2 Actavis, Inc.
12.2.1 Actavis, Inc. Corporation Information
12.2.2 Actavis, Inc. Description and Business Overview
12.2.3 Actavis, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Products Offered
12.2.5 Actavis, Inc. Recent Development
12.3 Bayer AG
12.3.1 Bayer AG Corporation Information
12.3.2 Bayer AG Description and Business Overview
12.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer AG Passive Transdermal Drug Delivery Products Offered
12.3.5 Bayer AG Recent Development
12.4 Boehringer Ingelheim GmbH
12.4.1 Boehringer Ingelheim GmbH Corporation Information
12.4.2 Boehringer Ingelheim GmbH Description and Business Overview
12.4.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Products Offered
12.4.5 Boehringer Ingelheim GmbH Recent Development
12.5 Corium International, Inc.
12.5.1 Corium International, Inc. Corporation Information
12.5.2 Corium International, Inc. Description and Business Overview
12.5.3 Corium International, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Products Offered
12.5.5 Corium International, Inc. Recent Development
12.6 Echo Therapeutics, Inc.
12.6.1 Echo Therapeutics, Inc. Corporation Information
12.6.2 Echo Therapeutics, Inc. Description and Business Overview
12.6.3 Echo Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Products Offered
12.6.5 Echo Therapeutics, Inc. Recent Development
12.7 GlaxoSmithKline plc
12.7.1 GlaxoSmithKline plc Corporation Information
12.7.2 GlaxoSmithKline plc Description and Business Overview
12.7.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Products Offered
12.7.5 GlaxoSmithKline plc Recent Development
12.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
12.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
12.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
12.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Products Offered
12.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
12.9 Mylan N.V.
12.9.1 Mylan N.V. Corporation Information
12.9.2 Mylan N.V. Description and Business Overview
12.9.3 Mylan N.V. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Mylan N.V. Passive Transdermal Drug Delivery Products Offered
12.9.5 Mylan N.V. Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Corporation Information
12.10.2 Novartis AG Description and Business Overview
12.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis AG Passive Transdermal Drug Delivery Products Offered
12.10.5 Novartis AG Recent Development
12.11 3M
12.11.1 3M Corporation Information
12.11.2 3M Description and Business Overview
12.11.3 3M Sales, Revenue and Gross Margin (2015-2020)
12.11.4 3M Passive Transdermal Drug Delivery Products Offered
12.11.5 3M Recent Development
12.12 Transdermal Corp.
12.12.1 Transdermal Corp. Corporation Information
12.12.2 Transdermal Corp. Description and Business Overview
12.12.3 Transdermal Corp. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Transdermal Corp. Products Offered
12.12.5 Transdermal Corp. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Passive Transdermal Drug Delivery Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Passive Transdermal Drug Delivery Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Passive Transdermal Drug Delivery Market Segments
Table 2. Ranking of Global Top Passive Transdermal Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Passive Transdermal Drug Delivery Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Microfluidics
Table 5. Major Manufacturers of Smart Pill Technology (SPT)
Table 6. Global Passive Transdermal Drug Delivery Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Passive Transdermal Drug Delivery Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Passive Transdermal Drug Delivery Sales by Regions 2015-2020 (K Units)
Table 9. Global Passive Transdermal Drug Delivery Sales Market Share by Regions (2015-2020)
Table 10. Global Passive Transdermal Drug Delivery Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Passive Transdermal Drug Delivery Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Passive Transdermal Drug Delivery Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Passive Transdermal Drug Delivery Sales Share by Manufacturers (2015-2020)
Table 14. Global Passive Transdermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Passive Transdermal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Passive Transdermal Drug Delivery as of 2019)
Table 16. Passive Transdermal Drug Delivery Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Passive Transdermal Drug Delivery Price (2015-2020) (USD/Unit)
Table 19. Passive Transdermal Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Passive Transdermal Drug Delivery Product Type
Table 21. Date of International Manufacturers Enter into Passive Transdermal Drug Delivery Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Passive Transdermal Drug Delivery Sales by Type (2015-2020) (K Units)
Table 24. Global Passive Transdermal Drug Delivery Sales Share by Type (2015-2020)
Table 25. Global Passive Transdermal Drug Delivery Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Passive Transdermal Drug Delivery Revenue Share by Type (2015-2020)
Table 27. Passive Transdermal Drug Delivery Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Passive Transdermal Drug Delivery Sales Share by Type (2021-2026)
Table 29. Global Passive Transdermal Drug Delivery Sales by Application (2015-2020) (K Units)
Table 30. Global Passive Transdermal Drug Delivery Sales Share by Application (2015-2020)
Table 31. Global Passive Transdermal Drug Delivery Sales Share by Application (2021-2026)
Table 32. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Passive Transdermal Drug Delivery Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Passive Transdermal Drug Delivery Sales (K Units) of Key Companies (2015-2020)
Table 36. China Passive Transdermal Drug Delivery Sales Share by Company (2015-2020)
Table 37. China Passive Transdermal Drug Delivery Revenue (US$ Million) by Company (2015-2020)
Table 38. China Passive Transdermal Drug Delivery Sales (K Units) by Type (2015-2020)
Table 39. China Passive Transdermal Drug Delivery Sales Share by Type (2015-2020)
Table 40. China Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Passive Transdermal Drug Delivery Price (K Units) by Type (2015-2020)
Table 42. China Passive Transdermal Drug Delivery Sales (K Units) by Type (2021-2026)
Table 43. China Passive Transdermal Drug Delivery Sales Share by Type (2021-2026)
Table 44. China Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Passive Transdermal Drug Delivery Revenue Share by Type (2021-2026)
Table 46. China Passive Transdermal Drug Delivery Price (K Units) by Type (2021-2026)
Table 47. China Passive Transdermal Drug Delivery Sales (K Units) by Application (2015-2020)
Table 48. China Passive Transdermal Drug Delivery Sales Share by Application (2015-2020)
Table 49. China Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Passive Transdermal Drug Delivery Sales (K Units) by Application (2021-2026)
Table 51. China Passive Transdermal Drug Delivery Sales Share by Application (2021-2026)
Table 52. China Passive Transdermal Drug Delivery Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Passive Transdermal Drug Delivery Revenue Share by Application (2021-2026)
Table 54. North America Passive Transdermal Drug Delivery Sales by Country (2015-2020) (K Units)
Table 55. North America Passive Transdermal Drug Delivery Sales Market Share by Country (2015-2020)
Table 56. North America Passive Transdermal Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Passive Transdermal Drug Delivery Revenue Market Share by Country (2015-2020)
Table 58. Europe Passive Transdermal Drug Delivery Sales by Country (2015-2020) (K Units)
Table 59. Europe Passive Transdermal Drug Delivery Sales Market Share by Country (2015-2020)
Table 60. Europe Passive Transdermal Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Passive Transdermal Drug Delivery Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Passive Transdermal Drug Delivery Revenue Market Share by Region (2015-2020)
Table 66. Latin America Passive Transdermal Drug Delivery Sales by Country (2015-2020) (K Units)
Table 67. Latin America Passive Transdermal Drug Delivery Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Passive Transdermal Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Passive Transdermal Drug Delivery Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Passive Transdermal Drug Delivery Revenue Market Share by Country (2015-2020)
Table 74. 3M Corporation Information
Table 75. 3M Description and Business Overview
Table 76. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. 3M Passive Transdermal Drug Delivery Product
Table 78. 3M Recent Development
Table 79. Actavis, Inc. Corporation Information
Table 80. Actavis, Inc. Description and Business Overview
Table 81. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Actavis, Inc. Product
Table 83. Actavis, Inc. Recent Development
Table 84. Bayer AG Corporation Information
Table 85. Bayer AG Description and Business Overview
Table 86. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Bayer AG Product
Table 88. Bayer AG Recent Development
Table 89. Boehringer Ingelheim GmbH Corporation Information
Table 90. Boehringer Ingelheim GmbH Description and Business Overview
Table 91. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Boehringer Ingelheim GmbH Product
Table 93. Boehringer Ingelheim GmbH Recent Development
Table 94. Corium International, Inc. Corporation Information
Table 95. Corium International, Inc. Description and Business Overview
Table 96. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Corium International, Inc. Product
Table 98. Corium International, Inc. Recent Development
Table 99. Echo Therapeutics, Inc. Corporation Information
Table 100. Echo Therapeutics, Inc. Description and Business Overview
Table 101. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Echo Therapeutics, Inc. Product
Table 103. Echo Therapeutics, Inc. Recent Development
Table 104. GlaxoSmithKline plc Corporation Information
Table 105. GlaxoSmithKline plc Description and Business Overview
Table 106. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. GlaxoSmithKline plc Product
Table 108. GlaxoSmithKline plc Recent Development
Table 109. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
Table 110. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
Table 111. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Product
Table 113. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
Table 114. Mylan N.V. Corporation Information
Table 115. Mylan N.V. Description and Business Overview
Table 116. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Mylan N.V. Product
Table 118. Mylan N.V. Recent Development
Table 119. Novartis AG Corporation Information
Table 120. Novartis AG Description and Business Overview
Table 121. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Novartis AG Product
Table 123. Novartis AG Recent Development
Table 124. Noven Pharmaceuticals, Inc. Corporation Information
Table 125. Noven Pharmaceuticals, Inc. Description and Business Overview
Table 126. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Noven Pharmaceuticals, Inc. Product
Table 128. Noven Pharmaceuticals, Inc. Recent Development
Table 129. Transdermal Corp. Corporation Information
Table 130. Transdermal Corp. Description and Business Overview
Table 131. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Transdermal Corp. Product
Table 133. Transdermal Corp. Recent Development
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Passive Transdermal Drug Delivery Players
Table 138. Passive Transdermal Drug Delivery Customers List
Table 139. Passive Transdermal Drug Delivery Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Passive Transdermal Drug Delivery Product Picture
Figure 2. Global Passive Transdermal Drug Delivery Sales Market Share by Type in 2020 & 2026
Figure 3. Microfluidics Product Picture
Figure 4. Smart Pill Technology (SPT) Product Picture
Figure 5. Global Passive Transdermal Drug Delivery Sales Market Share by Application in 2020 & 2026
Figure 6. Clinic
Figure 7. Hospital
Figure 8. Others
Figure 9. Passive Transdermal Drug Delivery Report Years Considered
Figure 10. Global Passive Transdermal Drug Delivery Market Size 2015-2026 (US$ Million)
Figure 11. Global Passive Transdermal Drug Delivery Sales 2015-2026 (K Units)
Figure 12. Global Passive Transdermal Drug Delivery Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2015-2020)
Figure 14. Global Passive Transdermal Drug Delivery Sales Market Share by Region in 2019
Figure 15. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2015-2020)
Figure 16. Global Passive Transdermal Drug Delivery Revenue Market Share by Region in 2019
Figure 17. Global Passive Transdermal Drug Delivery Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Passive Transdermal Drug Delivery Revenue in 2019
Figure 19. Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2015-2020)
Figure 21. Global Passive Transdermal Drug Delivery Sales Market Share by Type in 2019
Figure 22. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2015-2020)
Figure 23. Global Passive Transdermal Drug Delivery Revenue Market Share by Type in 2019
Figure 24. Global Passive Transdermal Drug Delivery Market Share by Price Range (2015-2020)
Figure 25. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2015-2020)
Figure 26. Global Passive Transdermal Drug Delivery Sales Market Share by Application in 2019
Figure 27. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2015-2020)
Figure 28. Global Passive Transdermal Drug Delivery Revenue Market Share by Application in 2019
Figure 29. China Passive Transdermal Drug Delivery Sales Growth Rate 2015-2026 (K Units)
Figure 30. China Passive Transdermal Drug Delivery Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. China Passive Transdermal Drug Delivery Market Share in Global Market 2015-2026
Figure 32. China 5 and 10 Largest Passive Transdermal Drug Delivery Players Market Share by Revenue in Passive Transdermal Drug Delivery in 2019
Figure 33. China Passive Transdermal Drug Delivery Revenue Share by Type (2015-2020)
Figure 34. China Passive Transdermal Drug Delivery Revenue Growth Rate by Type in 2015 & 2019
Figure 35. China Passive Transdermal Drug Delivery Revenue Share by Application (2015-2020)
Figure 36. China Passive Transdermal Drug Delivery Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Passive Transdermal Drug Delivery Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Passive Transdermal Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Passive Transdermal Drug Delivery Sales Market Share by Country in 2019
Figure 40. North America Passive Transdermal Drug Delivery Revenue Market Share by Country in 2019
Figure 41. U.S. Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Passive Transdermal Drug Delivery Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Passive Transdermal Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Passive Transdermal Drug Delivery Sales Market Share by Country in 2019
Figure 48. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country in 2019
Figure 49. Germany Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Passive Transdermal Drug Delivery Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Passive Transdermal Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Passive Transdermal Drug Delivery Sales Market Share by Region in 2019
Figure 62. Asia Pacific Passive Transdermal Drug Delivery Revenue Market Share by Region in 2019
Figure 63. China Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Passive Transdermal Drug Delivery Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Passive Transdermal Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Passive Transdermal Drug Delivery Sales Growth Rate (2015-

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs